| 2023-10-26 | -56.8% | legal | SEC EDGAR | SGHT 8-K: 7.01 and 8.01 (SEC Filing) |
| 2022-11-10 | +54.4% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2023-09-11 | -46.7% | legal | SEC EDGAR | SGHT 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-10-17 | +33.5% | legal | SEC EDGAR | SGHT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-10-17 | +33.5% | news | Stock Titan | 10.4M covered lives: Sight Sciences wins jurisdiction-wide Medicare fee for CPT 0563T with Jan 1, 2025 effective date - Stock Titan |
| 2026-03-05 | -29.6% | earnings | Moby | Sight Sciences, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-05 | -29.6% | earnings | GuruFocus.com | Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... |
| 2026-03-05 | -29.6% | earnings | MarketBeat | Sight Sciences Q4 Earnings Call Highlights |
| 2026-03-05 | -29.6% | earnings | Seeking Alpha | Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy |
| 2026-03-05 | -29.6% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript |
| 2025-11-07 | +28.7% | earnings | Seeking Alpha | Sight Sciences raises 2025 revenue guidance to $76M-$78M while accelerating TearCare commercialization |
| 2025-11-07 | +28.7% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript |
| 2026-03-04 | -24.9% | earnings | Motley Fool | Sight Sciences (SGHT) Q4 2025 Earnings Transcript |
| 2026-03-04 | -24.9% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.08 beats by $0.07, revenue of $20.4M beats by $0.06M |
| 2026-03-04 | -24.9% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-04 | -24.9% | earnings | Yahoo Finance | Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance |
| 2026-03-04 | -24.9% | earnings | Quiver Quantitative | Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative |
| 2026-03-04 | -24.9% | earnings | bitget.com | Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates - bitget.com |
| 2023-06-02 | -23.0% | legal | SEC EDGAR | SGHT 8-K: 7.01 and 8.01 (SEC Filing) |
| 2024-01-23 | -20.3% | legal | SEC EDGAR | SGHT 8-K: 1.01, 1.02, 2.03, 3.02, 7.01 (SEC Filing) |
| 2023-11-07 | +19.4% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-11-07 | -18.3% | legal | SEC EDGAR | SGHT 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2024-07-10 | +16.8% | news | Seeking Alpha | CVRx plunges, Sight Sciences jumps on proposed Medicare rate changes |
| 2025-11-06 | +16.7% | earnings | Seeking Alpha | Sight Sciences Non-GAAP EPS of -$0.16 beats by $0.10, revenue of $19.9M beats by $2.16M |
| 2025-11-06 | +16.7% | executive | Seeking Alpha | Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO |
| 2025-11-06 | +16.7% | legal | SEC EDGAR | SGHT 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-11-06 | +16.7% | earnings | Yahoo Finance | Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2025-11-06 | +16.7% | news | Stock Titan | [8-K] Sight Sciences, Inc. Reports Material Event - Stock Titan |
| 2024-08-01 | -15.6% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.25 beats by $0.04, revenue of $21.4M beats by $0.05M |
| 2024-08-01 | -15.6% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-09 | -15.6% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2025-08-08 | +15.5% | earnings | Seeking Alpha | Sight Sciences raises 2025 revenue guidance to $72M–$76M amid strong OMNI growth and strategic focus on MIGS leadership |
| 2025-08-08 | +15.5% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q2 2025 Earnings Call Transcript |
| 2022-07-20 | +15.5% | legal | SEC EDGAR | SGHT 8-K: 5.02 (SEC Filing) |
| 2025-08-07 | +14.5% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.23 beats by $0.04, revenue of $19.6M beats by $1.42M |
| 2025-08-07 | +14.5% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-10 | +12.6% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-22 | +12.1% | legal | SEC EDGAR | SGHT 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-03-24 | -12.1% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-08-03 | +11.8% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-12-28 | -11.7% | news | Seeking Alpha | Sight Sciences slips despite Medicare decision on glaucoma procedure (update) |
| 2022-03-16 | +10.8% | legal | SEC EDGAR | SGHT 8-K: 5.02 (SEC Filing) |
| 2025-11-21 | +10.3% | news | Seeking Alpha | Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap |
| 2023-01-09 | -10.2% | legal | SEC EDGAR | SGHT 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2024-08-03 | -9.6% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q2 2024 Earnings Call Transcript |
| 2022-05-12 | +9.1% | news | Seeking Alpha | Sight Sciences (SGHT) Investor Presentation - Slideshow (NASDAQ:SGHT) 2022-05-12 - Seeking Alpha |
| 2022-01-10 | +8.6% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-10 | +8.6% | news | Stocktwits | SGHT: Sight Sciences Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits |
| 2024-11-09 | +8.4% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q3 2024 Earnings Call Transcript |
| 2025-09-09 | -8.1% | news | Benzinga | What's Going On With Sight Sciences Stock Tuesday? - Sight Sciences (NASDAQ:SGHT) - Benzinga |
| 2023-04-03 | -7.5% | legal | SEC EDGAR | SGHT 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-01 | -7.5% | news | GlobeNewswire | Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting |
| 2026-04-01 | -7.5% | news | Stock Titan | SGHT (NASDAQ: SGHT) files Form 144 to sell 29,244 vested shares - Stock Titan |
| 2026-04-01 | -7.5% | news | Stock Titan | New dry eye data vs. Restasis joins Sight Sciences glaucoma studies at ASCRS - Stock Titan |
| 2026-04-01 | -7.5% | news | Stock Titan | Proposed share sales at SGHT (NASDAQ: SGHT) include 2,293 and 576 shares - Stock Titan |
| 2025-05-08 | +7.1% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.28 beats by $0.01, revenue of $17.5M beats by $0.99M |
| 2025-05-08 | +7.1% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-03 | -6.7% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2024-01-08 | +6.5% | earnings | Seeking Alpha | Sight Sciences says Q4 total revenue is expected to be between $18.6M and $18.8M |
| 2024-03-07 | +6.4% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.22 beats by $0.12, revenue of $18.8M misses by $0.6M |
| 2024-03-07 | +6.4% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-04-29 | +6.3% | legal | SEC EDGAR | SGHT 8-K: 8.01 and (SEC Filing) |
| 2026-01-13 | -6.3% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2026-01-13 | -6.3% | news | Quiver Quantitative | Sight Sciences Reports Preliminary Fourth Quarter and Full Year 2025 Financial Highlights - Quiver Quantitative |
| 2026-01-23 | -6.3% | news | AD HOC NEWS | Sight Sciences stock under pressure: Can SGHT’s slide turn into a deep value opportunity? - AD HOC NEWS |
| 2025-01-14 | -6.0% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2025-12-31 | -5.9% | news | Seeking Alpha | Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge |
| 2025-12-31 | -5.9% | earnings | Moomoo | Sight Sciences (NASDAQ:SGHT) Has Debt But No Earnings; Should You Worry? - Moomoo |
| 2025-12-31 | -5.9% | news | AD HOC NEWS | The Truth About Sight Sciences Inc (SGHT): Silent Wall Street Underdog Or Total Flop? - AD HOC NEWS |
| 2022-08-11 | -5.6% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2026-03-30 | -5.4% | news | GlobeNewswire | Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th |
| 2026-03-30 | -5.4% | news | Simply Wall St. | Arq And 2 Other Promising Penny Stocks |
| 2026-03-30 | -5.4% | legal | GlobeNewswire | Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent |
| 2026-03-30 | -5.4% | news | Stock Titan | Sight Sciences (NASDAQ: SGHT) awarded $34M plus 10% Hydrus royalties - Stock Titan |
| 2026-03-30 | -5.4% | earnings | Stock Titan | Court keeps $34 million award, 10% royalties in eye-stent patent fight - Stock Titan |
| 2026-03-30 | -5.4% | news | GlobeNewswire | Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th - GlobeNewswire |
| 2026-03-30 | -5.4% | legal | GlobeNewswire | Sight Sciences Secures Order on Post-Trial Motions That - GlobeNewswire |
| 2026-03-30 | -5.4% | news | TipRanks | Sight Sciences Wins Key Patent Ruling in Glaucoma Case - TipRanks |
| 2025-01-29 | -5.2% | news | Investing.com | Sight Sciences executives receive salary increases and bonus targets - Investing.com |
| 2021-08-12 | -5.2% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2024-12-11 | -5.1% | legal | SEC EDGAR | SGHT 8-K: 2.03 and 3.02 (SEC Filing) |
| 2025-08-27 | -5.1% | legal | SEC EDGAR | SGHT 8-K: 2.05, 5.02and7.01 (SEC Filing) |
| 2025-09-30 | -4.5% | legal | SEC EDGAR | SGHT 8-K: 1.01 and (SEC Filing) |
| 2024-05-02 | +4.4% | legal | SEC EDGAR | SGHT 8-K: 2.01, 7.01 (SEC Filing) |
| 2026-01-08 | -4.1% | news | simplywall.st | This Insider Has Just Sold Shares In Sight Sciences - simplywall.st |
| 2025-01-28 | +4.0% | legal | SEC EDGAR | SGHT 8-K: 5.02 (SEC Filing) |
| 2025-08-28 | -3.8% | news | Seeking Alpha | Sight Sciences Trying To Thread An Increasingly Narrow Needle |
| 2025-08-28 | -3.8% | news | Seeking Alpha | Sight Sciences Trying To Thread An Increasingly Narrow Needle (NASDAQ:SGHT) - Seeking Alpha |
| 2026-03-06 | +3.7% | news | GlobeNewswire | Sight Sciences Shareholders Are Encouraged to Reach Out to - GlobeNewswire |
| 2026-02-03 | -3.6% | legal | SEC EDGAR | SGHT 8-K: 1.01 (SEC Filing) |
| 2026-04-02 | -3.6% | news | Stock Titan | Insider sale notice: SGHT (NASDAQ: SGHT) 8,168 restricted shares - Stock Titan |
| 2026-04-02 | -3.6% | news | Stock Titan | Alison Bauerlein plans sale of 25,874 shares (SGHT) - Stock Titan |
| 2024-05-30 | +3.6% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2024-05-05 | -3.4% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q1 2024 Earnings Call Transcript |
| 2023-03-13 | +3.4% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2026-04-08 | -3.1% | news | Stock Titan | KCK Ltd. reports 1.44M shares in Sight Sciences (SGHT) — 2.7% stake - Stock Titan |
| 2026-04-08 | -3.1% | news | Xã Vĩnh Công | Will Sight Sciences (SGHT) Stock Fall Further | Price at $3.53, Up 0.86% - Bearish Pattern - Xã Vĩnh Công |
| 2024-02-02 | -2.8% | legal | SEC EDGAR | SGHT 8-K: 5.02 (SEC Filing) |
| 2024-03-26 | +2.5% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-04-24 | -2.5% | earnings | Stock Titan | Eyecare Tech Leader Sight Sciences Sets Q1 2025 Earnings Date: What Investors Should Watch - Stock Titan |
| 2024-11-08 | -2.5% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.22, revenue of $20.2M |
| 2026-04-21 | -2.4% | news | GlobeNewswire | Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-04-21 | -2.4% | news | Stock Titan | Sight Sciences will detail first-quarter results after market close May 6 - Stock Titan |
| 2022-04-18 | -2.2% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2025-07-29 | -2.2% | analyst | Stock Titan | Clinical Trial: TearCare Outperforms Restasis, Provides 2-Year Dry Eye Relief with Just Two Treatments - Stock Titan |
| 2024-03-08 | -2.1% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q4 2023 Earnings Call Transcript |
| 2026-02-09 | -1.9% | analyst | Seeking Alpha | From REITs to Retail: Small caps with the longest runs at bullish Quant ratings |
| 2026-04-23 | +1.7% | news | Stock Titan | Sight Sciences (NASDAQ: SGHT) awarded $55.4M and 10% Hydrus royalty - Stock Titan |
| 2021-11-10 | -1.7% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2025-03-05 | +1.5% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of -$0.23 in-line, revenue of $19.07M beats by $0.07M |
| 2025-03-05 | +1.5% | legal | SEC EDGAR | SGHT 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-05-04 | -1.5% | legal | SEC EDGAR | SGHT 8-K: 2.02 and (SEC Filing) |
| 2025-06-05 | -1.5% | legal | SEC EDGAR | SGHT 8-K: 5.02 and 5.07 (SEC Filing) |
| 2024-05-03 | +1.5% | earnings | Seeking Alpha | Sight Sciences GAAP EPS of $0.33, revenue of $19.3M |
| 2026-04-09 | -1.4% | earnings | MarketBeat | Sight Sciences (NASDAQ:SGHT) CFO James Rodberg Sells 7,231 Shares of Stock - MarketBeat |
| 2026-04-09 | -1.4% | executive | Stock Titan | Sight Sciences (SGHT) legal chief sells 13,761 shares for RSU tax obligations - Stock Titan |
| 2026-04-09 | -1.4% | executive | Stock Titan | Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan |
| 2026-04-09 | -1.4% | news | Investing.com South Africa | Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com South Africa |
| 2023-12-07 | +1.3% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2025-03-06 | -1.3% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q4 2024 Earnings Conference Call Transcript |
| 2026-01-21 | +1.2% | executive | Investing.com | Sight Sciences (SGHT) chief legal officer sells $41,758 in stock - Investing.com |
| 2026-01-21 | +1.2% | news | simplywall.st | Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge Could Signal Some Risk - simplywall.st |
| 2022-02-21 | -1.1% | news | Seeking Alpha | Sight Sciences (SGHT) Investor Presentation - Slideshow (NASDAQ:SGHT) 2022-02-21 - Seeking Alpha |
| 2026-04-06 | -1.1% | news | Stock Titan | Affiliate notice: SGHT (NASDAQ: SGHT) proposes common-share sale tied to vesting - Stock Titan |
| 2026-04-06 | -1.1% | news | Stock Titan | SGHT (NASDAQ: SGHT) sale notice: 13,761 restricted shares vesting - Stock Titan |
| 2026-04-22 | +1.0% | news | GlobeNewswire | Sight Sciences Announces the Release of its Sustainability Report |
| 2026-04-22 | +1.0% | news | Stock Titan | Sight Sciences says it donated to 24 programs supporting indigent care - Stock Titan |
| 2026-04-22 | +1.0% | news | Stock Titan | Sight Sciences (NASDAQ: SGHT) details 2026 meeting, director elections and auditor vote - Stock Titan |
| 2024-09-26 | +1.0% | legal | SEC EDGAR | SGHT 8-K: 8.01 (SEC Filing) |
| 2025-05-11 | +0.9% | earnings | Seeking Alpha | Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript |
| 2025-02-24 | -0.6% | news | Stock Titan | Can This Groundbreaking Glaucoma Treatment Transform Patient Care? New Data Reveals 3-Year Outcomes - Stock Titan |
| 2023-06-09 | +0.4% | legal | SEC EDGAR | SGHT 8-K: 7.01 and 8.01 (SEC Filing) |
| 2026-04-04 | +0.4% | legal | Stock Titan | SGHT SEC Filings - Sight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-03 | +0.4% | news | Stock Titan | [Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan |
| 2026-04-03 | +0.4% | news | Stock Titan | Sight Sciences (SGHT) CTO tax-related sale of 8,168 shares disclosed - Stock Titan |
| 2026-04-03 | +0.4% | news | Stock Titan | Sight Sciences (SGHT) EVP Brenton sells 2,869 shares for RSU tax obligations - Stock Titan |
| 2026-04-03 | +0.4% | news | Investing.com | Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) - Investing.com |
| 2026-04-03 | +0.4% | earnings | MarketBeat | Sight Sciences (NASDAQ:SGHT) EVP Brenton Taylor Sells 2,869 Shares - MarketBeat |
| 2025-09-10 | +0.3% | news | Seeking Alpha | Sight Sciences, Inc. (SGHT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) |
| 2023-12-18 | -0.3% | legal | SEC EDGAR | SGHT 8-K: 1.01 (SEC Filing) |
| 2022-03-04 | -0.2% | legal | SEC EDGAR | SGHT 8-K: 5.02 (SEC Filing) |
| 2021-07-15 | — | earnings | MarketBeat | Sight Sciences (SGHT) Stock Price, News & Analysis - MarketBeat |